Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration

Published:2016-01 Issue:1 Volume:123 Page:70-77.e1
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Solomon Sharon D.,Lindsley Kristina B.,Krzystolik Magdalena G.,Vedula Satyanarayana S.,Hawkins Barbara S.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference26 articles.

1. Pegaptanib for neovascular age-related macular degeneration;Gragoudas;N Engl J Med,2004

2. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

3. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

4. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration;Vedula;Cochrane Database Syst Rev,2008

5. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration;Solomon;Cochrane Database Syst Rev,2014

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LESS IS MORE;Retina;2024-05

2. Pro re nata anti-VEGF treatment in pachychoroid neovasculopathy compared with age-related macular degeneration based on optical coherence tomography;International Ophthalmology;2024-03-29

3. Häufigkeit und Wirkstoffverteilung intravitrealer Injektionen in deutschen Zentren 2015 bis 2021 – eine oregis-Studie;Die Ophthalmologie;2024-02-05

4. Aurora kinase B disruption suppresses pathological retinal angiogenesis by affecting cell cycle progression;Experimental Eye Research;2024-02

5. Anatomical and Functional Outcomes with Prompt versus Delayed Initiation of Anti-VEGF in Exudative Age-Related Macular Degeneration;Journal of Clinical Medicine;2023-12-25